S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.15%) $0.928
USD/NOK
(0.34%) $10.88
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.34%) $92.26

Realtime updates for iTeos Therapeutics, Inc. [ITOS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
33.33%
return -1.48%
SELL
50.00%
return -1.45%
Last Updated28 Mar 2024 @ 16:00

3.57% $ 13.64

SELL 62958 min ago

@ $10.28

Issued: 14 Feb 2024 @ 09:30


Return: 32.68%


Previous signal: Feb 12 - 15:25


Previous signal: Buy


Return: -3.95 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for iTeos Therapeutics, Inc.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients...

Stats
Today's Volume 343 107
Average Volume 265 678
Market Cap 488.90M
EPS $0 ( 2024-03-20 )
Next earnings date ( $-1.020 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.33
ATR14 $0.0130 (0.10%)
Insider Trading
Date Person Action Amount type
2024-03-07 Gall Matthew Buy 163 200 Stock Option (Right to Buy)
2024-03-07 Call Matthew Buy 225 000 Stock Option (Right to Buy)
2024-03-07 Mcgrath Yvonne Buy 153 600 Stock Option (Right to Buy)
2024-03-07 Detheux Michel Buy 590 400 Stock Option (Right to Buy)
2024-03-07 Desimone Jill Buy 44 766 Stock Option (Right to Buy)
INSIDER POWER
60.21
Last 98 transactions
Buy: 4 056 310 | Sell: 3 240 538

Volume Correlation

Long: -0.10 (neutral)
Short: -0.10 (neutral)
Signal:(63.667) Neutral

iTeos Therapeutics, Inc. Correlation

10 Most Positive Correlations
VERU0.964
AADI0.945
MDRX0.944
TWST0.941
SGMO0.941
LSBK0.939
BLNK0.936
ACRS0.936
AKTX0.936
ALHC0.936
10 Most Negative Correlations
CPTA-0.934
RAM-0.928
SGEN-0.924
TYHT-0.916
GPACU-0.906
DRNA-0.902
PESI-0.897
XPON-0.891
AMPH-0.886
MLAI-0.886

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iTeos Therapeutics, Inc. Correlation - Currency/Commodity

The country flag -0.09
( neutral )
The country flag -0.18
( neutral )
The country flag 0.00
( neutral )
The country flag 0.47
( neutral )
The country flag -0.39
( neutral )
The country flag -0.23
( neutral )

iTeos Therapeutics, Inc. Financials

Annual 2023
Revenue: $12.60M
Gross Profit: $11.70M (92.87 %)
EPS: $-3.15
Q4 2023
Revenue: $0
Gross Profit: $-233 000 (0.00 %)
EPS: $-0.850
Q3 2023
Revenue: $0
Gross Profit: $-224 000 (0.00 %)
EPS: $-0.900
Q2 2023
Revenue: $0
Gross Profit: $-198 000 (0.00 %)
EPS: $-0.960

Financial Reports:

No articles found.

iTeos Therapeutics, Inc.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators